BIOHAVEN LTD (BHVN)

VGG1110E1079 - Common Stock

50.04  -0.84 (-1.65%)

After market: 50.04 0 (0%)

Fundamental Rating

2

BHVN gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 564 industry peers in the Biotechnology industry. While BHVN has a great health rating, there are worries on its profitability. BHVN is valued expensive and it does not seem to be growing.



0

1. Profitability

1.1 Basic Checks

BHVN had negative earnings in the past year.
BHVN had a negative operating cash flow in the past year.
In the past 5 years BHVN always reported negative net income.
BHVN had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of -128.14%, BHVN is not doing good in the industry: 82.00% of the companies in the same industry are doing better.
BHVN's Return On Equity of -194.56% is on the low side compared to the rest of the industry. BHVN is outperformed by 68.98% of its industry peers.
Industry RankSector Rank
ROA -128.14%
ROE -194.56%
ROIC N/A
ROA(3y)-105.39%
ROA(5y)-115.24%
ROE(3y)-272.45%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BHVN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

7

2. Health

2.1 Basic Checks

The number of shares outstanding for BHVN has been increased compared to 1 year ago.
Compared to 5 years ago, BHVN has more shares outstanding
There is no outstanding debt for BHVN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

BHVN has an Altman-Z score of 9.01. This indicates that BHVN is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 9.01, BHVN belongs to the best of the industry, outperforming 83.07% of the companies in the same industry.
There is no outstanding debt for BHVN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 9.01
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

BHVN has a Current Ratio of 3.27. This indicates that BHVN is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.27, BHVN is doing worse than 63.99% of the companies in the same industry.
BHVN has a Quick Ratio of 3.27. This indicates that BHVN is financially healthy and has no problem in meeting its short term obligations.
BHVN has a worse Quick ratio (3.27) than 61.85% of its industry peers.
Industry RankSector Rank
Current Ratio 3.27
Quick Ratio 3.27

1

3. Growth

3.1 Past

The earnings per share for BHVN have decreased strongly by -32.23% in the last year.
EPS 1Y (TTM)-32.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-175.76%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

BHVN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.37% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-60.03%
EPS Next 2Y-6.76%
EPS Next 3Y0.79%
EPS Next 5Y14.37%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BHVN. In the last year negative earnings were reported.
Also next year BHVN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.76%
EPS Next 3Y0.79%

0

5. Dividend

5.1 Amount

BHVN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BIOHAVEN LTD

NYSE:BHVN (11/4/2024, 8:04:00 PM)

After market: 50.04 0 (0%)

50.04

-0.84 (-1.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap4.92B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -128.14%
ROE -194.56%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.27
Quick Ratio 3.27
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-32.23%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-60.03%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y